menu
    • menu

    Company profile for Merck & Co

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our goal is to lead the way to a healthier future. But we also care about how we get there together. As a company whose products touch the lives and well being of people around the world, we hold ourselves to a high standard. And we expect others to hold us to that same high standard. We believe in operating openly, honestly and with the highest degree of ethics and integrity. This includes: making sure that the compa...
    Our goal is to lead the way to a healthier future. But we also care about how we get there together. As a company whose products touch the lives and well being of people around the world, we hold ourselves to a high standard. And we expect others to hold us to that same high standard. We believe in operating openly, honestly and with the highest degree of ethics and integrity. This includes: making sure that the company complies with all applicable laws and regulations globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Merck & CoUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Merck Drive, P.O. Box 100 Whitehouse Station, NJ 08889-0100
    Telephone
    Telephone
    +1 732 422 7800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.merck.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1293

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour Global Ally in the Pharmaceutical IndustryYour Global Ally in the Pharmaceutical Industry

    Your Global Ally in the Pharmaceutical Industry
    Your Global Ally in the Pharmaceutical Industry

    reelYour Global Ally in the Pharmaceutical Industry

    This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

    Impressions: 99

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 233

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona

    10 Jul 2025

    // PRESS RELEASE

    https://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/

    PRESS RELEASE
    10 Jul 2025
    Share Share
    Merck to Unveil Hiv Prevention, Treatment Data at IAS 2025
    Merck to Unveil Hiv Prevention, Treatment Data at IAS 2025

    09 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/merck-to-present-new-research-data-across-its-hiv-prevention-and-treatment-pipeline-at-ias-2025-17375

    INDPHARMAPOST
    09 Jul 2025
    Share Share
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona

    09 Jul 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-nears-10-billion-deal-respiratory-drugmaker-verona-ft-reports-2025-07-09/

    REUTERS
    09 Jul 2025
    Share Share
    Merck's Q2 2025 Sales and Earnings Call Set for July 29
    Merck's Q2 2025 Sales and Earnings Call Set for July 29

    01 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250701671551/en/Merck-to-Hold-Second-Quarter-2025-Sales-and-Earnings-Conference-Call-July-29

    BUSINESSWIRE
    01 Jul 2025
    Share Share
    ACIP Backs Merck’s ENFLONSIA for RSV in Infants
    ACIP Backs Merck’s ENFLONSIA for RSV in Infants

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626825962/en/ACIP-Recommends-Use-of-Mercks-ENFLONSIA-clesrovimab-cfor-for-Prevention-of-Respiratory-Syncytial-Virus-RSV-Lower-Respiratory-Tract-Disease-in-Infants-Younger-than-8-Months-of-Age-Born-During-or-Entering-Their-First-RSV-Season

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    US CDC vaccine panel postpones vote on RSV therapies
    US CDC vaccine panel postpones vote on RSV therapies

    25 Jun 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-vaccine-panel-postpones-vote-rsv-therapies-2025-06-25/

    REUTERS
    25 Jun 2025
    Share Share

    Services

    Upload your portfolio for free, ask us

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Merck & Co. Inc and get a quotation

    Merck & Co. Inc is a supplier offers 146 products (APIs, Excipients or Intermediates).

    Find a price of Betamethasone bulk with DMF, CEP offered by Merck & Co. Inc

    Find a price of Betamethasone bulk with CEP offered by Merck & Co. Inc

    Find a price of Ivermectin bulk with CEP offered by Merck & Co. Inc

    Find a price of Loratadine bulk with CEP offered by Merck & Co. Inc

    Find a price of 2-Methoxyestradiol bulk offered by Merck & Co. Inc

    Find a price of 5-N,N-Dibenzylglycyl-Salicylamide bulk offered by Merck & Co. Inc

    Find a price of Arprinocid bulk offered by Merck & Co. Inc

    Find a price of Brompheniramine Maleate bulk offered by Merck & Co. Inc

    Find a price of Butorphanol Tartrate bulk offered by Merck & Co. Inc

    Find a price of CAS 50-28-2 bulk offered by Merck & Co. Inc

    Find a price of Chlorpheniramine Maleate bulk offered by Merck & Co. Inc

    Find a price of Conjugated Estrogens bulk offered by Merck & Co. Inc

    Find a price of Corticosterone bulk offered by Merck & Co. Inc

    Find a price of Danazol bulk offered by Merck & Co. Inc

    Find a price of Desogestrel bulk offered by Merck & Co. Inc

    Find a price of Dexamethasone bulk offered by Merck & Co. Inc

    Find a price of Dexamethasone Sodium Phosphate bulk offered by Merck & Co. Inc

    Find a price of Dexbrompheniramine Maleate bulk offered by Merck & Co. Inc

    Find a price of Dexchloropheniramine Maleate bulk offered by Merck & Co. Inc

    Find a price of Diethylstilbestrol bulk offered by Merck & Co. Inc

    Find a price of Diflunisal bulk offered by Merck & Co. Inc

    Find a price of Dihydrotestosterone bulk offered by Merck & Co. Inc

    Find a price of Diltiazem bulk offered by Merck & Co. Inc

    Find a price of Droperidol bulk offered by Merck & Co. Inc

    Find a price of Edrophonium Chloride bulk offered by Merck & Co. Inc

    Find a price of Enalapril Maleate bulk offered by Merck & Co. Inc

    Find a price of Estradiol bulk offered by Merck & Co. Inc

    Find a price of Estriol bulk offered by Merck & Co. Inc

    Find a price of Estrovarin bulk offered by Merck & Co. Inc

    Find a price of Ethinyl Estradiol bulk offered by Merck & Co. Inc

    Find a price of Fentanyl Citrate bulk offered by Merck & Co. Inc

    Find a price of Fluphenazine Decanoate bulk offered by Merck & Co. Inc

    Find a price of Heparin Sodium bulk offered by Merck & Co. Inc

    Find a price of Hyaluronic Acid bulk offered by Merck & Co. Inc

    Find a price of Imipramine Hydrochloride bulk offered by Merck & Co. Inc

    Find a price of Lovastatin bulk offered by Merck & Co. Inc

    Find a price of Medroxyprogesterone Acetate bulk offered by Merck & Co. Inc

    Find a price of Megestrol Acetate bulk offered by Merck & Co. Inc

    Find a price of Mestranol bulk offered by Merck & Co. Inc

    Find a price of Mk-6240 bulk offered by Merck & Co. Inc

    Find a price of Mk2048 bulk offered by Merck & Co. Inc

    Find a price of Nalbuphine Hydrochloride bulk offered by Merck & Co. Inc

    Find a price of Nalmefene Hydrochloride bulk offered by Merck & Co. Inc

    Find a price of Naltrexone bulk offered by Merck & Co. Inc

    Find a price of Neomycin Sulfate bulk offered by Merck & Co. Inc

    Find a price of Norandrostenedione bulk offered by Merck & Co. Inc

    Find a price of Norethisterone bulk offered by Merck & Co. Inc

    Find a price of Norethisterone Acetate bulk offered by Merck & Co. Inc

    Find a price of Norgestimate bulk offered by Merck & Co. Inc

    Find a price of Omeprazole Magnesium bulk offered by Merck & Co. Inc

    Find a price of Oxandrolone bulk offered by Merck & Co. Inc

    Find a price of Oxytocin bulk offered by Merck & Co. Inc

    Find a price of Pheniramine Maleate bulk offered by Merck & Co. Inc

    Find a price of Pimozide bulk offered by Merck & Co. Inc

    Find a price of Prasterone Acetate bulk offered by Merck & Co. Inc

    Find a price of Prednisolone Sodium Phosphate bulk offered by Merck & Co. Inc

    Find a price of Prochlorperazine Edisylate bulk offered by Merck & Co. Inc

    Find a price of Promethazine Hydrochloride bulk offered by Merck & Co. Inc

    Find a price of Pyridostigmine bulk offered by Merck & Co. Inc

    Find a price of Testosterone Propionate bulk offered by Merck & Co. Inc

    Find a price of Thiabendazole bulk offered by Merck & Co. Inc

    Find a price of Tibolone bulk offered by Merck & Co. Inc

    Find a price of Tubocurarine Chloride bulk offered by Merck & Co. Inc

    Find a price of Urofollitropin bulk offered by Merck & Co. Inc

    Find a price of Vitamin B12 bulk offered by Merck & Co. Inc

    Find a price of STERILE DILUENT bulk offered by Merck & Co. Inc

    Find a price of AMPROL SUPER PLUS (AMPROLIUM & ETHOPABATE) (VET) bulk offered by Merck & Co. Inc

    Find a price of FACILITY AND PROCEDURES IN OSS, THE NETHERLANDS - MOLENSTRAAT 110 bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HOBBESDON, HERFORDSHIRE, ENGLAND. bulk offered by Merck & Co. Inc

    Find a price of CORTATE (DESOXYCORTICOSTERONE ACETATE) bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WILSON, NORTH CAROLINA. bulk offered by Merck & Co. Inc

    Find a price of PREPARATION OF TEN STABLE ISOTOPE-LABELLED COMPOUNDS bulk offered by Merck & Co. Inc

    Find a price of MK-4176 DRUG SUBSTANCE bulk offered by Merck & Co. Inc

    Find a price of NITROGEN MUSTARDS bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Merck & Co. Inc

    Find a price of MANUF. CONTROL FACILITIES & PROCEDURES FOR DANVILLE PA PLANT bulk offered by Merck & Co. Inc

    Find a price of PORCINE INSULIN HIGHLY PURIFIED bulk offered by Merck & Co. Inc

    Find a price of AMPROLIUM MEDICATED FEED -(3-NITRO-4-HYDROXYPHENYLARSONIC ACID) (VET) bulk offered by Merck & Co. Inc

    Find a price of ORG 32489 RECOMBINANT FSH bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN OKAZAKI CITY, JAPAN. bulk offered by Merck & Co. Inc

    Find a price of PRO-STREP CRUMBLES (VET) bulk offered by Merck & Co. Inc

    Find a price of HADACIDIN SOD. DIHYDRATE (NSC 521778) & HADACIDIN POTASS. NSC 72962 bulk offered by Merck & Co. Inc

    Find a price of PRO-STREP IN SWINE (VET) bulk offered by Merck & Co. Inc

    Find a price of RATHDRUM, COUNTY WICKLOW, IRELAND bulk offered by Merck & Co. Inc

    Find a price of HYDROCORT. 21-PHOSPHATE & NEOMYCIN SO4--OPTHAL. SOL. 0.5% & INJECT bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURE AND CONTROL bulk offered by Merck & Co. Inc

    Find a price of PROCESS $ CONTROL DATE CONCERNING MANUFACTURE OF 2-ACETYLAMINA ETC. bulk offered by Merck & Co. Inc

    Find a price of L-000825058 bulk offered by Merck & Co. Inc

    Find a price of J-107088 bulk offered by Merck & Co. Inc

    Find a price of MANUF, CONTROL FACILITIES PROCEDURES FOR ALBANY, GA. PLANT bulk offered by Merck & Co. Inc

    Find a price of NORGESTOMET bulk offered by Merck & Co. Inc

    Find a price of L-651,392-00N,4-BROMO-2,7-DIMETHOXY-3H-PHENOTHIAZIN-3-ONE bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN LE PUY CEDEX, FRANCE. bulk offered by Merck & Co. Inc

    Find a price of 1-METHYL-1-(B-CHLOROETHYL) ETHYLENIMONIUM PICRYSULFONATE bulk offered by Merck & Co. Inc

    Find a price of FACILITIES AND OPERATING PROCEDURES IN CLERMONT-FERRAND,FRANCE bulk offered by Merck & Co. Inc

    Find a price of AMPROLIUM IN CHICKENS (VET) bulk offered by Merck & Co. Inc

    Find a price of BULK FORM OF DRUG PRODUCT L-590,153 PROCESSED RAHWAY, N.J. FACILITIES bulk offered by Merck & Co. Inc

    Find a price of MERCK bulk offered by Merck & Co. Inc

    Find a price of FACILS., METHODS & CONTROLS FOR PROCESSING & PACKAGING OF DRUG PRODS. bulk offered by Merck & Co. Inc

    Find a price of TECHNETIUM Tc 99M POLYPHOSPHATE KIT bulk offered by Merck & Co. Inc

    Find a price of MANUF&CONTROL FACILITIES&PROCEDURES AT SUBSIDIARY PLANT BARCELONETA,PR bulk offered by Merck & Co. Inc

    Find a price of MANUF. & CONTROL,FACILITIES & PROCEDURES-FOR ELKTON, VA. PLANT bulk offered by Merck & Co. Inc

    Find a price of MANUF.CONTROL,FACILITIES &PROCEDURES-AT RAHWAY, NJ PLANT bulk offered by Merck & Co. Inc

    Find a price of Aprepitant bulk offered by Merck & Co. Inc

    Find a price of Avobenzona bulk offered by Merck & Co. Inc

    Find a price of Betamethasone Sodium Phosphate bulk offered by Merck & Co. Inc

    Find a price of Boceprevir bulk offered by Merck & Co. Inc

    Find a price of Boric Acid bulk offered by Merck & Co. Inc

    Find a price of CAS 532-40-1 bulk offered by Merck & Co. Inc

    Find a price of CAS 654671-77-9 bulk offered by Merck & Co. Inc

    Find a price of CAS 66376-36-1 bulk offered by Merck & Co. Inc

    Find a price of Caspofungin bulk offered by Merck & Co. Inc

    Find a price of Choriogonadotropin Alfa bulk offered by Merck & Co. Inc

    Find a price of Cilastatin bulk offered by Merck & Co. Inc

    Find a price of Cilastatin Sodium bulk offered by Merck & Co. Inc

    Find a price of Cocarboxylase bulk offered by Merck & Co. Inc

    Find a price of Cocarboxylase Tetrahydrate bulk offered by Merck & Co. Inc

    Find a price of Desloratadine bulk offered by Merck & Co. Inc

    Find a price of Doravirine bulk offered by Merck & Co. Inc

    Find a price of Elbasvir bulk offered by Merck & Co. Inc

    Find a price of Ensulizole bulk offered by Merck & Co. Inc

    Find a price of Ertapenem bulk offered by Merck & Co. Inc

    Find a price of Ezetimibe bulk offered by Merck & Co. Inc

    Find a price of Fenbendazole bulk offered by Merck & Co. Inc

    Find a price of Florfenicol bulk offered by Merck & Co. Inc

    Find a price of Flunixin Meglumine bulk offered by Merck & Co. Inc

    Find a price of Gentamicin Sulfate bulk offered by Merck & Co. Inc

    Find a price of Grazoprevir bulk offered by Merck & Co. Inc

    Find a price of Imipenem bulk offered by Merck & Co. Inc

    Find a price of Loratadine bulk offered by Merck & Co. Inc

    Find a price of Meglumine bulk offered by Merck & Co. Inc

    Find a price of Metformin bulk offered by Merck & Co. Inc

    Find a price of Milbemycin Oxime bulk offered by Merck & Co. Inc

    Find a price of Posaconazole bulk offered by Merck & Co. Inc

    Find a price of Potassium Phosphate bulk offered by Merck & Co. Inc

    Find a price of Raltegravir Potassium bulk offered by Merck & Co. Inc

    Find a price of Rocuronium Bromide bulk offered by Merck & Co. Inc

    Find a price of Simvastatin bulk offered by Merck & Co. Inc

    Find a price of Sitagliptin Phosphate bulk offered by Merck & Co. Inc

    Find a price of Sodium Fluoride bulk offered by Merck & Co. Inc

    Find a price of Suvorexant bulk offered by Merck & Co. Inc

    Find a price of Trisodium Citrate Dihydrate bulk offered by Merck & Co. Inc

    Find a price of Zinc Oxide bulk offered by Merck & Co. Inc

    Find a price of LUPROSTIOL bulk offered by Merck & Co. Inc

    Find a price of MANUFACTURING OPERATIONS bulk offered by Merck & Co. Inc

    Find a price of Lettermovir bulk offered by Merck & Co. Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search